
News|Articles|April 1, 2002
Don't stop statins in inpatients with ACS
Stopping statins after the onset of symptoms completely negates the drugs'protective effect in hospitalized patients with acute coronary syndromes(ACS). So concludes a new subgroup analysis of the PRISM trial.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
4
Could GLP-1s help with cognitive symptoms, pychosis of schizophrenia?
5























